PMID- 9437410 OWN - NLM STAT- MEDLINE DCOM- 19980203 LR - 20221207 IS - 0954-6820 (Print) IS - 0954-6820 (Linking) VI - 242 IP - 6 DP - 1997 Dec TI - No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure. PG - 491-5 AB - OBJECTIVES: To determine whether furosemide treatment in congestive heart failure (CHF) patients is associated with thiamine deficiency. DESIGN: Patients without heart failure and without diuretic treatment were included to compare with patients with CHF belonging to New York Heart Association (NYHA) functional class II and III-IV, respectively, and receiving furosemide therapy. SETTING: All patients were recruited from the emergency ward of the cardiology section. Huddinge University Hospital, where they were admitted due to CHF or acute myocardial infarction. SUBJECTS: Ninety-nine patients were included from whom a blood sample was taken, as well as routine admission blood samples for the analysis of thiamine diphosphate (TPP) concentrations. Patients taking vitamin preparations were excluded. MAIN OUTCOME MEASURES: Blood TPP concentrations were measured by high performance liquid chromatography (HPLC) and compared between the patient groups by the use of ANOVA. RESULTS: No significant difference was found between the groups in blood TPP concentrations. CONCLUSIONS: Thiamine deficiency may not be a complication of furosemide treatment in the studied Swedish patient population. FAU - Yue, Q Y AU - Yue QY AD - Department of Clinical Pharmacology, Huddinge University Hospital, Sweden. FAU - Beermann, B AU - Beermann B FAU - Lindstrom, B AU - Lindstrom B FAU - Nyquist, O AU - Nyquist O LA - eng PT - Journal Article PL - England TA - J Intern Med JT - Journal of internal medicine JID - 8904841 RN - 0 (Diuretics) RN - 7LXU5N7ZO5 (Furosemide) RN - Q57971654Y (Thiamine Pyrophosphate) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Chromatography, High Pressure Liquid MH - Diuretics/*adverse effects/therapeutic use MH - Female MH - Furosemide/*adverse effects/therapeutic use MH - Heart Failure/*blood/*drug therapy MH - Humans MH - Male MH - Middle Aged MH - Sweden MH - Thiamine Pyrophosphate/*blood/deficiency MH - *White People EDAT- 1998/01/23 00:00 MHDA- 1998/01/23 00:01 CRDT- 1998/01/23 00:00 PHST- 1998/01/23 00:00 [pubmed] PHST- 1998/01/23 00:01 [medline] PHST- 1998/01/23 00:00 [entrez] AID - 10.1111/j.1365-2796.1997.tb00022.x [doi] PST - ppublish SO - J Intern Med. 1997 Dec;242(6):491-5. doi: 10.1111/j.1365-2796.1997.tb00022.x.